La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Melexis Bilan de santé
Santé financière contrôle des critères 5/6
Melexis possède un total de capitaux propres de €553.6M et une dette totale de €229.8M, ce qui porte son ratio d'endettement à 41.5%. Son actif total et son passif total sont €891.1M et de €337.5M. L'EBIT de Melexis est €260.8M ce qui fait que son ratio de couverture des intérêts 34.8. Elle dispose de liquidités et de placements à court terme de €38.7M.
Informations clés
41.5%
Ratio d'endettement
€229.82m
Dette
| Ratio de couverture des intérêts | 28.2x |
| Argent liquide | €38.55m |
| Fonds propres | €553.59m |
| Total du passif | €337.51m |
| Total des actifs | €891.10m |
Mises à jour récentes de la santé financière
Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22
Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 15These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely
Jun 08Recent updates
Should You Think About Buying Melexis NV (EBR:MELE) Now?
Oct 01Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Aug 31There's Reason For Concern Over Melexis NV's (EBR:MELE) Price
Aug 19Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Aug 02A Look At The Fair Value Of Melexis NV (EBR:MELE)
Jul 04Is There Now An Opportunity In Melexis NV (EBR:MELE)?
Jun 20Melexis (EBR:MELE) Knows How To Allocate Capital
Jun 07Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment
May 08Calculating The Fair Value Of Melexis NV (EBR:MELE)
Mar 27At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Mar 14Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital
Feb 28Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Feb 15Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02What Does Melexis NV's (EBR:MELE) Share Price Indicate?
Dec 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Nov 27Melexis (EBR:MELE) Knows How To Allocate Capital
Nov 15Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)
Nov 03Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 10Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Sep 26Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Sep 02Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Aug 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Aug 05Melexis (EBR:MELE) Might Become A Compounding Machine
Jul 13Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?
Jun 29Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)
Jun 02At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Apr 11With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case
Mar 27Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jan 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Dec 24Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 24Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 18Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 04Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 20We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease
Sep 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 05Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Aug 22Melexis (EBR:MELE) Will Pay A Dividend Of €0.91
Aug 04Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?
Jul 11Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Jun 27Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?
Jun 13Should You Think About Buying Melexis NV (EBR:MELE) Now?
Mar 01Calculating The Fair Value Of Melexis NV (EBR:MELE)
Feb 14Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Dec 06Should You Think About Buying Melexis NV (EBR:MELE) Now?
Nov 18Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 29Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 15Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around
Jul 18Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jun 21These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely
Jun 08Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price
Apr 11Analyse de la situation financière
Passif à court terme: Les actifs à court terme de MELE ( €450.9M ) dépassent ses passifs à court terme ( €95.9M ).
Passif à long terme: Les actifs à court terme de MELE ( €450.9M ) dépassent ses passifs à long terme ( €241.6M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de MELE ( 34.5% ) est considéré comme satisfaisant.
Réduire la dette: Le ratio d'endettement de MELE est passé de 19.4% à 41.5% au cours des 5 dernières années.
Couverture de la dette: La dette de MELE est bien couverte par le flux de trésorerie opérationnel ( 66.4% ).
Couverture des intérêts: Les paiements d'intérêts de MELE sur sa dette sont bien couverts par l'EBIT ( 34.8 x couverture).